]>
IRCT20181121041715N1 IRCT 2020-08-18 Esfahan University of Medical Sciences The effect of garlic on quality of life and improvement of cardiac function in patients with heart failure garlic The effect of garlic on quality of life and improvement of cardiac function in patients with heart failure 2020-08-20 anticipated 140 Complete https://irct.ir/trial/49715 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Single, Purpose: Treatment, Randomization description: After that, the eligible patients are listed and based on block randomization, they are divided into two groups of intervention and control. In the randomized block method, the number of each block is considered to be 4 people. . For example, BABA permutation, so the first person who is eligible and enters the study receives the envelope b or placebo of the second person a or medicine and the third person b and the fourth person a, Blinding description: The present study is a randomized clinical trial with a control group receiving placebo and three-blind. The researcher or the person making the measurements, the patients and the data analyzer will be unaware of the drug code and placebo. . 1 Heart failure. Control group: The patient who receives the placebo. Yes - There is a plan to make this available What will be shared: The results are published and communicated to everyone When: 2020 To whom: The results are published and communicated to everyone Conditions: heart Failure Where to obtain: dr shafiee How to obtain: Official letter to Dr. Shafiee Comments:
public sima azish
Salman Farsi St. Chamran Heart Hospital
esfahan Iran (Islamic Republic of) 8166173414 +98 31 3261 1406 sima.azish@yahoo.com Esfahan University of Medical Sciences scientific davood shafiee
Salman Farsi St. Chamran Hospital
esfahan Iran (Islamic Republic of) 8166173414 +98 31 3261 1406 d.shafie87@gmail.com Esfahan University of Medical Sciences Iran (Islamic Republic of) Patients with heart failure in the age range of 18 years and above. For patients diagnosed at least 3 months in advance according to the New York Heart Association classification in Class III and II Their discharge fraction is reported to be less than 45%. Receiving common and standard medications for heart failure. Women should not be pregnant or breastfeeding and should use safe methods of contraception at reproductive age Do not suffer from mental illnesses, thyroid, anemia, obstructive pulmonary disease, malignancies, hepatitis, kidney and liver failure, uncontrolled diabetes and uncontrolled hypertension, gastrointestinal diseases. The patient's blood pressure is below 100/180. 18 years no limit Both I50 Heart failure Placebo Control group: The patient who receives the placebo EF. Timepoint: EF-40. Method of measurement: ECKO. Esfahan University of Medical Sciences Approved 2019-09-29 Ethics Committee of Isfahan Medical School Salman Farsi St. Chamran Heart Hospital esfahan Isfehan Iran (Islamic Republic of)